Medication info
Fincab 60/5 mg (Pimasartan Potassium, Esamlodipine)

Fincab 60/5 mg (Pimasartan Potassium, Esamlodipine)

Prescription medicationTabletOral
Ingredient · strength
Fimasartan Potassium Trihydrate›66.01mg / 1 tabletS-Amlodipine Besylate 2.5 Hydrate›7.48mg / 1 tablet
Manufacturer / importer
Eden Pharma Co., Ltd.
Appearance
Orange, rounded square film-coated tablet
Packaging
30 tablets/bottle, 300 tablets/bottle
Approval status
Active

MFDS item code 202300089 · Approved 2023.01.06 · Insurance code 628902190

Summary

Main use
Treatment of essential hypertension not controlled with fimasartan potassium monotherapy
Who takes it
Adults · Children
Adult dose
Adults The recommended dose of this medicine is 1 tablet once daily, taken with water, regardless of meals. It is recommended to take it at the same time each day, if possible (e.g., in the morning). Before starting this medicine, it is recommended that the dose be adjusted using fimasartan. However, if blood pressure is not controlled as described below, a direct switch to this medicine may be considered. ㆍ 30/2.5 mg: For patients whose blood pressure is not adequately controlled with fimasartan 30 mg monotherapy. ㆍ 60/2.5 mg: For patients whose blood pressure is not adequately controlled with fimasartan 60 mg monotherapy. ㆍ 60/5 mg: For patients whose blood pressure is not adequately controlled with fimasartan 60 mg monotherapy or this medicine 60/2.5 mg. Patients taking fimasartan and S-amlodipine (amlodipine) concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience. Elderly patients No initial dose adjustment is necessary in elderly patients aged 70 years or younger. Patients with renal impairment No dose adjustment is necessary in patients with mild to moderate renal impairment (creatinine clearance 30 ~ 80 mL/min). However, in patients with severe renal impairment (creatinine clearance < 30 mL/min), treatment should be initiated with this medicine containing fimasartan 30 mg. Patients with hepatic impairment No dose adjustment is necessary in patients with mild hepatic impairment. This medicine should not be administered to patients with moderate to severe hepatic impairment.
Child dose
The safety and efficacy of this medicine have not been established in pediatric and adolescent patients aged 18 years or younger.

Ingredients

Manufacturer
Eden Pharma Co., Ltd.

Efficacy & effects

Treatment of essential hypertension not controlled with fimasartan potassium monotherapy

  • Essential hypertension
View approved original text

Pimasartan potassium is used to effectively lower blood pressure in patients with essential hypertension when blood pressure is not adequately controlled with monotherapy.

How to take

Adult dose

Adults The recommended dose of this medicine is 1 tablet once daily, taken with water, regardless of meals. It is recommended to take it at the same time each day, if possible (e.g., in the morning). Before starting this medicine, it is recommended that the dose be adjusted using fimasartan. However, if blood pressure is not controlled as described below, a direct switch to this medicine may be considered. ㆍ 30/2.5 mg: For patients whose blood pressure is not adequately controlled with fimasartan 30 mg monotherapy. ㆍ 60/2.5 mg: For patients whose blood pressure is not adequately controlled with fimasartan 60 mg monotherapy. ㆍ 60/5 mg: For patients whose blood pressure is not adequately controlled with fimasartan 60 mg monotherapy or this medicine 60/2.5 mg. Patients taking fimasartan and S-amlodipine (amlodipine) concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience. Elderly patients No initial dose adjustment is necessary in elderly patients aged 70 years or younger. Patients with renal impairment No dose adjustment is necessary in patients with mild to moderate renal impairment (creatinine clearance 30 ~ 80 mL/min). However, in patients with severe renal impairment (creatinine clearance < 30 mL/min), treatment should be initiated with this medicine containing fimasartan 30 mg. Patients with hepatic impairment No dose adjustment is necessary in patients with mild hepatic impairment. This medicine should not be administered to patients with moderate to severe hepatic impairment.

Child dose

The safety and efficacy of this medicine have not been established in pediatric and adolescent patients aged 18 years or younger.

Precautions

This medication can cause serious harm or death to the fetus and newborn if taken during the second and third trimesters of pregnancy. Therefore, if pregnancy is confirmed, usage should be discontinued immediately. Individuals who are allergic to the main ingredients of this medication or similar substances, pregnant or breastfeeding women, patients undergoing dialysis, patients with moderate to severe liver impairment, patients with bile duct obstruction, and those with specific kidney dysfunction or diabetes should not take this medication. Patients with low blood volume or sodium deficiency, impaired renal function, renovascular hypertension, certain heart valve diseases, severe hypotension, elderly patients, and those allergic to specific pigments should use this medication carefully. Possible side effects when taking this medication may include dizziness, headache, edema, urinary disturbances, insomnia, flushing, and serious adverse reactions have been reported rarely. Patients with hypotension or electrolyte imbalance should correct their condition before taking this medication and carefully monitor symptoms during treatment, and take appropriate measures if hypotension occurs. This medication may increase blood potassium levels, so patients with heart failure or renal disease should undergo regular blood tests. Precaution is needed for certain kidney disease patients due to the risk of worsening renal function. There may be interactions when taken with other antihypertensives or specific medications, so it's essential to inform your healthcare provider about any ongoing medication. Pregnant or breastfeeding women should avoid using this medication, and breastfeeding should be stopped if taking this medication. It is recommended not to use this medication in children under the age of 18, as safety and efficacy have not been established. Elderly patients may be more sensitive to this medication, requiring careful monitoring. Patients with moderate to severe liver impairment should not take this medication. Overdose may lead to symptoms such as hypotension and cardiac arrhythmias, and immediate medical attention should be sought. This medicine should be kept out of the reach of children, and transferring it to another container may compromise its quality.

Side effects

Dizziness, orthostatic dizziness, headache, facial swelling, peripheral edema, urination disorders, insomnia, flushing, syncope, sedation, migraine, indigestion, vomiting, nausea, upper abdominal pain, weakness, foreign body sensation, elevated liver enzyme levels, decreased platelet count, increased serum creatine phosphokinase, cough, muscle contraction, musculoskeletal rigidity, itching, localized urticaria, facial flushing, erectile dysfunction, epilepsy, amyotrophic lateral sclerosis, neuropathy, neuronitis, facial paralysis, normal-pressure hydrocephalus, spinal canal stenosis, acute pancreatitis, bowel obstruction, hemorrhagic duodenal ulcer, appendicitis, hemorrhoids, abdominal pain, intracranial hemorrhage, transient ischemic attack, atherosclerosis, exacerbation of cerebral infarction, cerebral hemorrhage, liver cancer, colon cancer, neoplasm of unspecified nature, cervical cancer, prostate cancer, acute kidney failure, chronic kidney failure, renal stones, pyelonephritis, urinary incontinence, rhinitis, pulmonary fibrosis, pharyngitis, pneumonia, lung disease, death, exacerbation of back pain, osteoarthritis, arthropathy, hypoglycemia, hyperkalemia, pulmonary embolism, purpura, bradycardia, atrial fibrillation, coronary artery disease, aortic stenosis, heart failure, hypertension, acute hepatitis, benign pituitary neoplasm, otitis media, uterine prolapse, recurrent cancer, chest pain, weakness, fatigue, pain, weight gain, weight loss, hypotension, vasculitis, tension elevation, decreased sensitivity, paresthesia, peripheral neuropathy, dysgeusia, tremor, extrapyramidal disorder, gynecomastia, change in bowel habits, dry mouth, gastritis, gingival hypertrophy, pancreatitis, hyperglycemia, arthralgia, lower back pain, muscle cramps, myalgia, leukopenia, thrombocytopenia, mood changes, dyspnea, hair loss, hyperhidrosis, purpura, skin discoloration, urticaria, toxic epidermal necrolysis, tinnitus, visual disturbances, increased urinary frequency, nocturia, hepatitis, jaundice, pruritus, angioedema, erythema multiforme, myocardial infarction, arrhythmia, chest discomfort, hypotension, sinoatrial block, atrioventricular block, abdominal discomfort, epigastric pain, diarrhea, loose stools, constipation, skin flushing, maculopapular rash, heaviness, warmth, impaired glucose tolerance, weakness, symptoms of hypotension due to depletion of blood volume and sodium, hyperkalemia, increased serum creatinine, increased blood urea, acute renal failure, loss of consciousness, dyspnea, severe hypotension, pulmonary edema, blood pressure drop, blood pressure rise, blood pressure fluctuations, purpura, fatty liver, mesenteric edema, abdominal pain, nausea, vomiting, diarrhea

Not everyone experiences these, and they can vary from person to person.

Storage

This medication is sensitive to light and should be stored in a container that does not allow light to enter. Additionally, it is recommended to store the medication at room temperature between 1°C and 30°C to maintain its efficacy and safety.

Appearance and packaging

Appearance

Orange, rounded square film-coated tablet

Package unit

30 tablets/bottle, 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.